Financials
- Market Capitalization 95.11 M
- Employee 14
- Founded 2017
- CEO N/A
- Website www.equilliumbio.com
- Headquarter Delaware, United States
- FIGI BBG00LSL8C10
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.97
ratio cours/chiffre d'affaires
220.4
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3888 | ATRA Atara Biotherapeutics, Inc. - Common Stock | 9.40 USD | -0.84% | +3.30% | +3.41% | -36.27% | 94.35 M USD | ||
| 3894 | PYPD PolyPid Ltd. - Ordinary Shares | 5.06 USD | -0.20% | -2.32% | -2.32% | +59.62% | 92.11 M USD | ||
| 3902 | RLYB Rallybio Corporation - Common Stock | 16.93 USD | -0.53% | +0.65% | +1.20% | +3286.00% | 89.91 M USD | ||
| 3916 | ICCC ImmuCell Corporation - Common Stock | 9.60 USD | -2.04% | -0.83% | -2.04% | +41.18% | 87.19 M USD |